110 ALLEN ROAD, BASKING RIDGE, NJ
Material disclosure
Lisata Therapeutics Enters Amendment to Merger Agreement with Kuva Labs
Other Events
Waiver to Agreement and Plan of Merger
Q2
Q1
Amended Annual Report
FY 2025
Q3
FY 2024
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Definitive Proxy Statement
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Third Party
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Correspondence